Literature DB >> 6897087

Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis.

J A Delmez, E Slatopolsky, K J Martin, B N Gearing, H R Harter.   

Abstract

The effects of continuous ambulatory peritoneal dialysis on parathyroid hormone (PTH) and mineral metabolism were evaluated in ten patients. Utilizing a PTH radioimmunoassay, which measures both intact hormone and carboxyl-terminal PTH fragments, it was found that the mean clearance of immunoreactive parathyroid hormone was 1.5 +/- 0.73 ml/min (SEM) yielding a daily net removal of 13.6 +/- 3.2% of estimated total extracellular parathyroid hormone. Gel electrophoresis of the dialysate revealed the presence of both intact parathyroid hormone and fragments in a similar pattern to that of peripheral plasma. Normal levels of 25-(OH) vitamin D and vitamin D binding protein were observed prior to the initiation of continuous ambulatory peritoneal dialysis and following 6 months of treatment. Timed dialysate collections (N = 93) demonstrated a daily calcium influx of only 9.9 +/- 9.7 mg. The daily removal of phosphorus was 308.4 +/- 15.5 mg. Despite elevated serum magnesium levels in all patients, the net daily removal was inadequate (31.2 +/- 15.5 mg). It was concluded that: (1) Unlike chronic hemodialysis, continuous ambulatory peritoneal dialysis removes significant amounts of parathyroid hormone. (2) Normal 25-(OH) vitamin D and vitamin D binding protein levels are maintained with continuous ambulatory peritoneal dialysis despite large protein losses. (3) Substantial amounts of phosphorus are removed with continuous ambulatory peritoneal dialysis but not to an extent that precludes use of phosphorus binders. (4) Dialysate containing lower magnesium and possibly higher calcium concentrations should be made available to improve mineral homeostasis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897087     DOI: 10.1038/ki.1982.110

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Hyperphosphataemia in renal failure: causes, consequences and current management.

Authors:  Fouad Albaaj; Alastair Hutchison
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Some hormones, minerals and vitamin D in continuous ambulatory peritoneal dialysis.

Authors:  L Janicka; A Ksiazek; Z Twardowski; F Kokot
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

3.  Clearance of Magnesium in Peritoneal Dialysis Patients: A Single-Center Study.

Authors:  Guiyan Li; Li Zhang; Haibin Ren; Baodi Huang; Chunxia Mao; Annan Zhou
Journal:  Blood Purif       Date:  2019-01-30       Impact factor: 2.614

4.  Loss via peritoneal fluid as a factor for low 25(OH)D3 level in peritoneal dialysis patients.

Authors:  Garip Sahin; Ismail Kirli; Basar Sirmagul; Ertugrul Colak; Ahmet Ugur Yalcin
Journal:  Int Urol Nephrol       Date:  2009-04-29       Impact factor: 2.370

5.  Hyperparathyroidism after kidney transplantation: a retrospective case controlled study.

Authors:  J Vlcek; U Binswanger; G Keusch; J Záruba
Journal:  Klin Wochenschr       Date:  1991-09-16

6.  The impact of pretransplant 25-hydroxy vitamin D deficiency on subsequent graft function: an observational study.

Authors:  Hyunwook Kim; Shin-Wook Kang; Tae-Hyun Yoo; Myoung Soo Kim; Soon Il Kim; Yu Seun Kim; Kyu Hun Choi
Journal:  BMC Nephrol       Date:  2012-07-10       Impact factor: 2.388

7.  Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate.

Authors:  Ismail A Mohammed; Alastair J Hutchison
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

8.  Transperitoneal calcium balance in anuric continuous ambulatory peritoneal dialysis and automated peritoneal dialysis patients.

Authors:  Chieko Hamada; Yasuhiko Tomino
Journal:  Int J Nephrol       Date:  2013-07-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.